EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities



Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities



Clinical and Experimental Immunology 48(1): 249-255



A new procedure, based on centrifugation through multiple discontinuous gradients of polyvinylpyrrolidone-coated silica particles has been developed for the separation of almost pure eosinophils from blood samples of healthy donors. When this technique is employed for the purification of eosinophils from the peripheral blood of patients with parasitic diseases, two cell fractions almost pure in eosinophil granulocytes are harvested at different densities. Preliminary results, concerning the characterization of these cell fractions, indicate that in the terms of detectable membrane receptors and K cell activity, two distinct eosinophil subpopulations can be recognized.

(PDF emailed within 1 workday: $29.90)

Accession: 001085906

Download citation: RISBibTeXText

PMID: 7083641



Related references

Human eosinophils and parasitic diseases 2. characterization of 2 cell fractions isolated at different densities. Clinical and Experimental Immunology 48(1): 249-255, 1982

Human eosinophils and parasitic diseases: light and electron microscopy evidence of interaction with sheep erythrocyte. Clinical and Experimental Immunology 39(1): 247-253, 1980

Human eosinophils and parasitic diseases--III. Beta-interferon increases eosinophil IgG-Fc receptor expression and capacity. International Journal of Immunopharmacology 8(5): 479-485, 1986

Human eosinophils and parasitic diseases iii. beta interferon increases eosinophil immunoglobulin g fc receptor expression and capacity. International Journal of Immunopharmacology 8(5): 479-486, 1986

Human eosinophils and parasitic diseases light microscopy and electron microscopy evidence of interaction with sheep erythrocyte. Clinical & Experimental Immunology 39(1): 247-254, 1980

Eosinophils in parasitic diseases. Makino, S, Fukuda, T Eosinophils: Biological and clinical aspects: 391-402, 1993

Morphology of eosinophils during parasitic diseases. Khematologiya i Kr"voprelivaniya 22(3): 33-39, 1982

Significance of eosinophils in parasitic diseases. Parassitologia 24(1): 59-71, 1982

The significance of eosinophils in parasitic diseases. Parassitologia 24(1): 59-71, 1982

Different densities of human eosinophils respond differently to PAF and IL-5. Journal of Microbiology, Immunology, and Infection 32(1): 21-25, 2001

Eosinophils in parasitic diseases: properties of an eosinophil activating factor (EAF). EOS Rome 8(1-2): 33-41, 1988

The separation of eosinophils and the formation of spontaneous rosettes in parasitic diseases. Giornale di Malattie Infettive e Parassitarie 31(10): 849-850, 1979

Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunology and Allergy Clinics of North America 35(3): 413-437, 2016

Studies on protein fractions isolated from human plasma. Kininogenase activity in human plasma fractions isolated with ether and ethanol. British Journal of Haematology 18(1): 29-44, 1970

Fc epsilon receptor II expression in parasitic diseases: effects of cytokines on IgE-dependent activation of eosinophils. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 21b: 975-982, 1991